SciencePower’s is to redefining postbiotics through next-generation fermentation science — bridging discovery, clinical validation, and real-world health applications.
Check back for updates on:
SciencePower, a next-generation postbiotic platform company, today announced that it has entered into a license agreement with Mayo Clinic. The agreement enables collaborative research led by Mayo Clinic investigators to explore the potential of SciencePower’s proprietary postbiotic compositions in breast cancer biology.
Read More
SciencePower is proud to announce that preclinical findings generated by its internal research team will be presented at the upcoming San Antonio Breast Cancer Symposium (SABCS), taking place December 9-12, 2025, as part of our ongoing collaborative program with Mayo Clinic.
Read More